Formulation and evaluation of meloxicam gels for topical administration

Saudi Pharmaceutical Journal

Volumn 14, Issue 3-4, 2006, Pages 155-162

  El Megrab, Nagia A ^a   El Nahas, Hanan M ^a   Balata, Gehan F ^a  

^a Zagazig University   (Egypt)

Author keywords

Carrageenan; Hydrogels; Lipogels; Meloxicam; Microemulsion gels

Indexed keywords

ALCOHOL; CARBOMER; CARBOPOL 940; DODECYL SULFATE SODIUM; DRUG SOLVENT; MELOXICAM; MEXICAM; MONOGLYCERYLSTEARATE; OLEIC ACID; OLEIC ACID ETHYL ESTER; PIROXICAM; PLACEBO; POLYSORBATE 80; PROPYLENE GLYCOL; STEARIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; GEL; HYDROGEL; MALE; MICROEMULSION; NONHUMAN; PAW EDEMA; RABBIT; RAT; SKIN PENETRATION;

EID: 33845659096     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gupta S.K, Bansal P, Bhardwaj R.k, Jaiswal J and Velpandian, T. Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application. J. Pharmacol. Bioph. Res. 2002;15 (2):105-111.
2. Rafiee-Tehrani M. and Mehramizi A. In-vitro release studies of piroxicam from oil-in-water creams and hydroalcoholic gel topical formulation. Drug Dev. Ind. Pharm., 2000; 26(4): 409-414.
3. Arellano A, Santoyo S, Martin C and Ygartua P. Influence of propylene glycol and isopropyl myristate on the in-vitro percutaneous penetration of declofinace sodium from capobol gels. Eur. J. Pharm. Sci. 1999; 7(2): 129-135.
4. Arellano A, Santoyo S, Martn C, Ygartua P. Surfactant effect on the in-vitro percutaneous absorption of declofinac sodium. Eur. J. Drug Metab. Pharmacokinet. 1998; 23(2): 307-312.
5. Dreher F, Walde P, Walther P and Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J. Control. Rel., 1997; 45: 131-140.
6. Nasseri A. A, Aboofazeli R, Zia H and Needham T.E. Lecithin-stabilized microemulsion: an organogel for topical application of ketorolac tromethamine. I: phase behavior studies. Iranian J. Pharm. Res. 2003; 1: 65-66.
7. Thacharodi D and Panduranga K R. Transdermal absorption of nifedipine from microemulsions of lipophilic skin penetration enhancers. Int. J. Pharm. 1994; 111: 235-240.
8. Nicola R, Marisa D.Z, Eugenio R. and Dalla Fini, G. Drug release from lipogel according to gelling conditions and mechanical treatment. Drug Dev. Ind. Pharm. 1996; 22(2): 125-134.
9. Nicola R, Eugenio R, Marisa D.Z. and Enrico R. Kinetics of release and simulated absorption of methyl nicotinate from different ointment formulation: in-vitro-in-vivo correlation. Pharmazie. 1996; 15(2): 113-116.
10. Nicola R, Eugenio R. and Enrico R. Effect of gelling conditions and mechanical treatment on drug availability from a lipogel. Drug Dev. Ind. Pharm. 2001; 27(2): 165-170.
11. Larrucea E, Arellano A, Santoyo S. and Ygartua P. Interaction of tenoxicam with cyclodextrins and its influence on the in-vitro percutaneous penetration of drug. ibdi., 2001; 27(3): 251-260.
12. Abu-Zaid S. S, El-Ghamry H. A, Hammad M, Mokhtar M. Phase study and characterization of certain developed multicomponent colloidal systems and their potential application as earner for an antimicrobial agent. Alex. J. Pharm. Sci. 2005; 19(2): 131-140.
13. Al-Suwayeh S. A. Transdermal delivery of isoradipine through excised rabbit skin effect of vehicle and drug concentration. Saudi Pharm. J. 2003; 11(1-2): 46-52.
14. Gonsho A, Imanidis G, Vogt P, Kern E. R, Tsuge H. Su, M.H; Choi S.H and Higuchi, W. Controlled (trans) dermal delivery of an antiviral agent (Acyclovir). I: an in-vivo animal model for efficacy evaluation in cutaneous HSV-Infection. Int. J. Pharm. 1990; 65(3): 183-194.
15. Rhee G. J, Woo J. S, Hwang S. J, Lee Y. W. and Lee C. H. Topical oleo-hydrogel preparation of ketoprofen with enhanced skin permeability. Drug Dev. Ind. Pharm. 1999; 25 (6): 717-726.
16. Wada Y, Etoh Y, Ohira A, Kiamata H, Koide T, Ishihama H. and Mizushima Y. Percutaneous absorption and anti-inflammatory activity of indomethcin in ointment. J. Pharm. Pharmacol. 1982; 34: 467-468.
17. Gad S. C, Animal Models in Toxicology. Gad, S.C and Chenglis, P.C: Marcel Dekker, Inc., New York, 1992, 825.
18. Balata G. F. Master Thesis, Zagazig University, Egypt Formulation and evaluation of certain anti-inflammatory Drugs in emulgels. 1999, 131.
19. Higuchi W. I. Analysis of data on the medical release from topical ointments. J. Pharm. Sci. 1962; 51: 802-804.
20. El-Laithy H. M. and El-Shaboury K.M.F. The Development of Cutina Lipogels and Microemulsion Gel for Topical Administration of Fluconazole. AAPS Pharm. Sci. Tech. 2002; 3(4); article 35:1-9.
21. Ceschel G. C., Maffei C. and Lombardi B.S. Correlation between the transdermal permeation of ketoprofen and its solubility in mixtures of a pH 6.5 phosphate buffer and various solvent. Drug Deliv. 2002: 9(1); 39-45.
22. Hüttenrauch R, Flicke S. and Baumann V. State of order, properties and pynamics of structure in shear-crystallized ointments. Pharmazie. 1982; 37(1): 25-28.
23. Ugri-Hunyadvàri E. and Eros I. Studium der Gelstruktur VonKunstvaslinen. Pharm. Ind. 1986; 48: 969-972.
24. Obata Y., Takayama K., Maitani Y., Machida Y., and Nagai T. Effect of ethanol on the permeation of ionized and non ionized declofenac. Int. J. Pharm. 1993; 89: 191-198.
25. Megrab A.N., William A.C. and Barry B.W. Oestradiol permeation across human skin, silastic and snak skin membranes: the effect of ethanol: water co-solvent systems. Int. J. Pharm. 1995; 116: 101-112.
26. Chi S.C and Jun H.W. Release rate of ketoprofen from poloxamer gel in a membraneless diffusion cell. J. Pharm. Sci. 1991; 80(3): 280-283.
27. Go Y, Teruaki H., Tetsuya H., Toshinobu S., Kazuhiko J., Kenji S., and Yasunori M. Skin disposition of drugs after topical application in hairless rats. Chem. Pharm. Bull. 1999; (6): 749-754.
28. Bernhard P. W. and Bernhard C. L. Skin penetration of nonsteroidal anti-inflammatory drugs out of a lipophilic vehicle: influence of the viable epidermis. J. Pharm. Sci. 2000; 88(12): 1326-1331.
29. Fergany A.M. Topical permeation characteristics of diclofenac sodium from Na CMC gels In comparison with conventional gel formulation. Drug Dev. Ind. Pharm. 2001; 27(10): 1083-1097.